Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Gennaio 2022

Archivio

✕

31 gennaio 2022

2092

Men with HIV are more likely to be prescribed dolutegravir than women

Men with HIV are more likely to be prescribed dolutegravir than women

Women are much less likely to be prescribed the highly-effective HIV antiretroviral, dolutegravir (DTG), than men according to a study published in the Annals of Internal Medicine. The study, led by Dr Matthew Romo, reviewed the medical records of 134,672 patients from ...

31 gennaio 2022

2093

UNAIDS: HIV testing and treatment much lower in men than women

UNAIDS: HIV testing and treatment much lower in men than women

According to analysis by UNAIDS, in 2020 testing and treatment targets were almost reached for adult women (aged 15 and above) living with HIV. However, amongst men, these figures were significantly lower. Compared to women living with HIV, there are 740 000 more men ...

31 gennaio 2022

2234

Moderna starts clinical trial for mRNA based HIV vaccine

Moderna starts clinical trial for mRNA based HIV vaccine

Thursday 27th January 2022, Moderna announced that they have launched their clinical trail of a mRNA-based HIV vaccine - with the first doses being given that same day. Built on an mRNA (messenger RNA) platform, as used for Moderna’s COVID-19 vaccination, it is hoped ...